UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 8, 2007

MICROMED CARDIOVASCULAR, INC.

(Exact name of registrant as specified in its charter)

Delaware

000-51487

90-0265161

(State or other jurisdiction

of incorporation)

(Commission File Number)

(IRS Employer

Identification No.)

8965 Interchange Drive

Houston, Texas

77054

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: (713) 838-9210

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(b) On June 8, 2007, Juliet Markovich tendered her resignation as chief financial officer of MicroMed Cardiovascular, Inc., effective June 20, 2007, to pursue another employment opportunity. The resignation was not related to any disagreement between Ms. Markovich and the Company.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


	MICROMED CARDIOVASCULAR, INC.

Date: June 13, 2007	By:	/s/ Juliet Markovich
		Juliet Markovich
		Chief Financial Officer
		(Duly Appointed Officer)

MICROMED CARDIOVASCULAR INC 8-K